Sponsored Links
Lymphoma Information Network » Lymphoma Info » Chemotherapy - Cyclophosphamide (Cytoxan)

Chemotherapy - Cyclophosphamide (Cytoxan)

Cyclophosphamide (brand names Cytoxan, Neosar in the US, cytoxan or procytox in Canada) is a chemotherapy agent used in the treatment of Non-Hodgkin's lymphoma (NHL) and other forms of cancer. For NHL it is more often than not given in conjunction with other chemotherapy agents in a multidrug regimen. This drug is an alkalyzing agent, disrupting cancer growth.

Before taking this medicine: Inform the doctor if you have had heart problems or lung disease. It should not be taken while pregnant and not while breast feeding without your doctors' advice. This drug can affect fertility - you may wish to discuss this with your doctor.

While taking this medicine: It is important to keep in close contact with the doctor who will monitor dosage and effects. If you have surgery or emergency treatment, tell the doctor/dentist you are taking or have taken this medication. Drinking of fluids, up to 2 liters (quarts) a day is encouraged to prevent urinary tract damage. Stay away from those who have infectious diseases - this drug lowers resistance to infection.

Short Term Side Effects: Common: nausea and vomiting (ask your doctor about drugs to counteract nausea), diarrhea, menstrual irregularity, alopecia (hair loss), fatigue, darkening of nails or skin; Less Common: check with your doctor if bruising or unusual bleeding occurs, cough/shortness of breath/breathing problems, fever, chills, sore throat.

Long Term Side Effects: hair loss (alopecia) during use - hair growth should return after treatment. This drug has been known to affect fertility.

Cyclophosphamide is the "C" in CHOP chemotherapy for NHL

Cyclophosphamide is also being studied for use in conjunction with the Zevalin® radiolabeled isotope therapy for certain types of NHL.

Patients who are looking for more advanced treatment or who have lymphoma that does not respond to standard treatment may want to consider a clinical study. Click here to find clinical trials in your area.

Sponsored Links

Cancer Support Groups

SupportGroups.com build awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Related Articles

For more information on Non-Hodgkin's Lymphoma, please see the following pages:

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries

Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.
lymphomas